Design and evaluation of a self-microemulsifying drug delivery system for apigenin

Drug Development and Industrial Pharmacy

Volumn 39, Issue 5, 2013, Pages 662-669

  Zhao, Lili ^a   Zhang, Lin ^a   Meng, Lin ^a   Wang, Jing ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apigenin; Dissolution; SMEDDS; Solubility

Indexed keywords

APIGENIN; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; MANNITOL;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; MICROEMULSION; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, ORAL; APIGENIN; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; PARTICLE SIZE; SOLUBILITY;

EID: 84875907608     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.687378     Document Type: Article

References (24)

1. Zheng PW, Chiang LC, Lin CC. (2005). Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci, 76:1367-1379.
2. Patel D, Shukla S, Gupta S. (2007). Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncol, 30:233-245.
3. Zhong Y, Krisanapun C, Lee SH, Nualsanit T, Sams C, Peungvicha P et al. (2010). Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53. Eur J Cancer, 46:3365-3374.
4. Wang BJ, Yang S, Li D. (2008). Pre-formulation study on apigenin in solid lipid nanoparticles. Practical Pharm Clin Remedies, 11:323-324.
5. Zhu W, Yu A, Wang W, Dong R, Wu J, Zhai G. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm, 360:184-190.
6. Zhang P, Liu Y, Feng N, Xu J. (2008). Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm, 355:269-276.
7. Wu W, Wang Y, Que L. (2006). Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm, 63:288-294.
8. Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. (2010). Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm, 76:475-485.
9. Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK et al. (2009). Oral bioavailability enhancement of exemestane from self- microemulsifying drug delivery system (SMEDDS). AAPS Pharm Sci Tech, 10:906-916.
10. Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. (2004). Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull, 27:1993-1999.
11. Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA, Eisen HJ. (1998). Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc, 30:1892-1894.
12. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP et al. (2009). Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm, 72:539-545.
13. Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm, 329:166-172.
14. Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z et al. (2010). Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int J Pharm, 383:170-177.
15. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm, 167:155-164.
16. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H et al. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm, 371:148-155.
17. Kompany-Zareh M, Khoshkam M. (2008). Application of chemometrics methods with kinetic constraints for estimation of rate constants of second order consecutive reactions. Anal Sci, 24:637-645.
18. Narang AS, Delmarre D, Gao D. (2007). Stable drug encapsulation in micelles and microemulsions. Int J Pharm, 345:9-25.
19. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274:65-73.
20. Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179-188.
21. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. (2010). Selfemulsifying drug delivery systems: An approach to enhance oral bioavailability. Drug Discov Today, 15:958-965.
22. Gao Y, Wang Y, Ma Y, Yu A, Cai F, Shao W et al. (2009). Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf B Biointerfaces, 71:306-314.
23. Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173-182.
24. Qi S, Xi L, Dan Y, Wei J. (2010). Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system. Chem Pharm Bull, 58: 639-643.